← HCA Healthcare, Inc. HCA
Market Price
$404.67
Market Cap
$91.24B
P/E Ratio
14.28
Revenue (FY 2025)
↑7.1% YoY
$75.60B
3-Yr CAGR: 7.9%
Net Income
↑17.8% YoY
$6.78B
Net Margin: 9.0%
Free Cash Flow
↑36.4% YoY
$7.69B
FCF Yield: 8.43%
EPS (Diluted)
↑28.8% YoY
$28.33
Basic: $28.70
Return on Equity
Efficiency
N/A
ROA: 11.2%
⚡ N/A due to negative equity (share buybacks or other)
📊 Multi-Year Historical Performance & Trends
Financial Performance History
Revenue, Net Income & Free Cash Flow
Margins Trend (%)
Gross, Operating & Net Margins
Balance Sheet Strength
Cash, Debt & Equity
Cash Flow Generation
Operating Cash Flow vs CapEx vs FCF
📈 Year-over-Year (YoY) Growth History (HCA)
All monetary values in millions ($M)| Fiscal Year | Revenue | Revenue YoY | Gross Profit | Net Income | Net Inc YoY | Diluted EPS | EPS YoY | Op. Cash Flow | Free Cash Flow | FCF YoY |
|---|---|---|---|---|---|---|---|---|---|---|
| FY 2016 | $41,490.0M | — | $15,660.0M | $2,890.0M | — | $7.30 | — | $5,653.0M | $2,893.0M | — |
| FY 2017 | $43,614.0M | +5.1% | $16,239.0M | $2,216.0M | -23.3% | $5.95 | -18.5% | $5,426.0M | $2,411.0M | -16.7% |
| FY 2018 | $46,677.0M | +7.0% | $17,528.0M | $3,787.0M | +70.9% | $10.66 | +79.2% | $6,761.0M | $3,188.0M | +32.2% |
| FY 2019 | $51,336.0M | +10.0% | $19,295.0M | $3,505.0M | -7.4% | $10.07 | -5.5% | $7,602.0M | $3,444.0M | +8.0% |
| FY 2020 | $51,533.0M | +0.4% | $19,290.0M | $3,754.0M | +7.1% | $10.93 | +8.5% | $9,232.0M | $6,397.0M | +85.7% |
| FY 2021 | $58,752.0M | +14.0% | $22,492.0M | $6,956.0M | +85.3% | $21.16 | +93.6% | $8,959.0M | $5,382.0M | -15.9% |
| FY 2022 | $60,233.0M | +2.5% | $23,177.0M | $5,643.0M | -18.9% | $19.15 | -9.5% | $8,522.0M | $4,127.0M | -23.3% |
| FY 2023 | $64,968.0M | +7.9% | $25,579.0M | $5,242.0M | -7.1% | $18.97 | -0.9% | $9,431.0M | $4,687.0M | +13.6% |
| FY 2024 | $70,603.0M | +8.7% | $28,678.0M | $5,760.0M | +9.9% | $22.00 | +16.0% | $10,514.0M | $5,639.0M | +20.3% |
| FY 2025 | $75,600.0M | +7.1% | $31,374.0M | $6,784.0M | +17.8% | $28.33 | +28.8% | $12,636.0M | $7,692.0M | +36.4% |
Valuation
Market Price
$404.67
Market Cap
$91.24B
Enterprise Value
$131.80B
P/E Ratio
14.28
P/B Ratio
N/A
FCF Yield
8.43%
Dividend Yield
0.71%
Shares Outstanding
Profitability & Margins
Gross Margin
41.50%
Operating Margin
13.01%
Net Margin
8.97%
Return on Equity (ROE)
N/A (Negative Equity)
Return on Assets (ROA)
11.17%
Asset Turnover
1.25x
Revenue 3-Yr CAGR
7.87%
Financial Health & Liquidity
Current Ratio
0.97
Cash Ratio
0.06
Debt / Equity
-6.903
Debt / Assets
0.685
Cash & Equivalents
$1.04B
Total Debt
$41.60B
Book Value / Share
$-27.17
Cash Flow Efficiency
Operating Cash Flow
$12.64B
Capital Expenditures (CapEx)
$4.94B
Free Cash Flow
$7.69B
OCF / Revenue
16.71%
FCF / Revenue
10.17%
FCF 3-Yr CAGR
23.07%
Per Share Metrics
EPS (Diluted)
$28.33
EPS (Basic)
$28.70
Dividends / Share
$2.88
Book Value / Share
$-27.17
EPS YoY Growth
28.77%
Balance Sheet (FY 2025)
Total Assets
$60.72B
Total Liabilities
$60.72B
Stockholders' Equity
-$6.03B
Current Assets
$15.78B
Current Liabilities
$16.35B